MedPath
HSA Approval

PRIMAX EYE DROPS 5 mg/ml

SIN13168P

PRIMAX EYE DROPS 5 mg/ml

PRIMAX EYE DROPS 5 mg/ml

January 17, 2006

PETER CHIA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPETER CHIA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

OPHTHALMIC

Medical Information

S01HA04

proxymetacaine

Manufacturer Information

PETER CHIA MARKETING PTE. LTD.

Ashford Laboratories Ltd

Active Ingredients

Proparacaine HCl

5.0 mg/ml

Proparacaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PRIMAX EYE DROPS 5 mg/ml - HSA Approval | MedPath